Yuichi Chikata, Hiroshi Iwata, Katsutoshi Miyosawa, Ryo Naito, Takuma Koike, Soshi Moriya, Hidetoshi Yasuda, Takehiro Funamizu, Shinichiro Doi, Hirohisa Endo, Hideki Wada, Manabu Ogita, Tomotaka Dohi, Takatoshi Kasai, Kikuo Isoda, Shinya Okazaki, Katsumi Miyauchi, Tohru Minamino
BACKGROUND: Since the complication of diabetes mellitus (DM) is a risk for adverse cardiovascular outcomes in patients with coronary artery disease (CAD), appropriate risk estimation is needed in diabetic patients following percutaneous coronary intervention (PCI). However, there is no useful biomarker to predict outcomes in this population. Although stromal cell derived factor-1α (SDF-1α), a circulating chemokine, was shown to have cardioprotective roles, the prognostic impact of SDF-1α in diabetic patients with CAD is yet to be fully elucidated...
March 30, 2024: Cardiovascular Diabetology